Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger
Condition:   Severe Rotavirus GastroenteritisInterventions:   Biological: Rotavirus vaccine (BRV-PV);   Biological: PlaceboSponsors:   Epicentre;   Medecins Sans Frontieres;   Serum Institute of India Limited;   Forum Santé Niger;   Ministry of Public Health Niger;   Children's Hospital Medical Center, CincinnatiNot yet recruiting - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 20, 2014 Category: Research Source Type: clinical trials